Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.37 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL101143 | 0.97 | USP2 (0.68) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL3108971 | 0.95 | USP2 (0.72) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL11042040 | 0.92 | USP2 (0.75) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL6230528 | 0.90 | USP2 (0.79) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL29837928 | 0.90 | USP2 (0.79) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL8619644 | 0.90 | USP2 (0.79) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL8620507 | 0.90 | USP2 (0.79) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL8622815 | 0.90 | USP2 (0.79) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL8622282 | 0.90 | USP2 (0.79) | USP2HTTLMNAALDH1A1HSD17B10 | |
| SCHEMBL4266733 | 0.89 | USP2 (0.58) | USP2HTTLMNAALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2019-01-17 | — | — | US | disclosed |
| US-5290769-A | Applying compositions for skin disorders | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1994-03-01 | — | — | US | disclosed |
| US-5110814-A | Antiinflammatory agents; ulcerative colitis | ASTA PHARMA AG (DE) | 1992-05-05 | — | — | US | disclosed |
| EP-0419998-A2 | Use of alkylphosphonic acid derivatives for the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1991-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | COG2, PTGER2, MGLL | USP2 212/4885HTT 4671/4885LMNA 1399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.